Advances and challenges in management of large vessel vasculitis
Glucocorticoids (GC) remains the mainstay for management of large vessel vasculitis (LVV). Recent introduction of interleukin-6 signaling blocker, tocilizumab has substantially changed the practice in management of patients with LVV, in particular, giant cell arteritis (GCA). Benefit of tocilizumab to patients with Takayasu arteritis (TAK) is supported by observational studies, but randomized clinical trials are lacking. Addition of tocilizumab enables reduction of the total amount of GC in patients with GCA, but GC burden remains high and to be further reduced. Ongoing studies aim at minimal use of GC or even GC-free. Tumor necrosis factor inhibitors appear to be beneficial to TAK despite their ineffectiveness to GCA. Randomized clinical trials are undergoing to target other inflammatory cytokines in both GCA and TAK. Janus kinase inhibitors alone or in combination with conventional disease modifying anti-rheumatic drugs showed promising results in treatment of TAK.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Advances and challenges in management of large vessel vasculitis ; volume:4 ; number:4 ; year:2023 ; pages:188-195 ; extent:8
Rheumatology and immunology research ; 4, Heft 4 (2023), 188-195 (gesamt 8)
- Creator
- DOI
-
10.2478/rir-2023-0028
- URN
-
urn:nbn:de:101:1-2023122013040653077904
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Other Objects (12)
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study
Animal models for large vessel vasculitis – The unmet need
Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report
Large-vessel vasculitis in graft-versus-host disease: a case report
Settings and artefacts relevant for Doppler ultrasound in large vessel vasculitis
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis
18F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis
Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
Large vessel vasculitis evaluation by CTA: impact of deep-learning reconstruction and “dark blood” technique
Therapeutic advances in the treatment of vasculitis
ANCA-associated vasculitis in childhood: recent advances
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study
Animal models for large vessel vasculitis – The unmet need
Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report
Large-vessel vasculitis in graft-versus-host disease: a case report
Settings and artefacts relevant for Doppler ultrasound in large vessel vasculitis
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis
18F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis
Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
Large vessel vasculitis evaluation by CTA: impact of deep-learning reconstruction and “dark blood” technique
Therapeutic advances in the treatment of vasculitis
ANCA-associated vasculitis in childhood: recent advances
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study
Animal models for large vessel vasculitis – The unmet need
Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis
Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report
Large-vessel vasculitis in graft-versus-host disease: a case report
Settings and artefacts relevant for Doppler ultrasound in large vessel vasculitis
Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis
18F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis
Significant association between clinical characteristics and changes in peripheral immuno-phenotype in large vessel vasculitis
Large vessel vasculitis evaluation by CTA: impact of deep-learning reconstruction and “dark blood” technique
Therapeutic advances in the treatment of vasculitis